Ligature-induced periodontitis in mice potentially accelerates CD4+ T-cell senescence and exacerbates rheumatoid arthritis

Our immune system ages in a way that can fuel chronic inflammation and autoimmune disease — a process called immunosenescence. This mouse study asked whether gum disease (periodontitis) can speed up that aging process in a specific immune cell type, the CD4+ helper T cell, and whether that in turn makes inflammatory joint disease worse. Researchers induced periodontitis in mice by tying silk ligatures around their molars, then tracked the behavior of their immune cells over time. They found that although the senescence markers on T cells looked similar between periodontitis and control mice under normal resting conditions, the periodontitis group's T cells showed dramatically accelerated signs of aging when pushed to divide in the lab — peaking around 18 weeks of age. These 'senescence-primed' T cells pumped out more inflammatory signals (SASP cytokines), stopped dividing as readily, and showed distinct gene-expression changes compared to controls. Critically, when these T cells were transferred into immune-deficient mice and arthritis was triggered, the disease was significantly worse than in control transfers. The study proposes a new cellular chain of events: gum inflammation quietly primes helper T cells toward premature aging, these cells circulate systemically, and when they encounter the right trigger, they amplify autoimmune joint destruction.

• PD-1+CD153+ double-positive 'senescent' CD4+ T cells were not significantly elevated in vivo in periodontitis mice, but were significantly more abundant after in vitro stimulation with IL-2 and anti-TCRβ/CD28, with the difference peaking at 18 weeks of age in the ligature-induced periodontitis (LIP) group.
• SASP cytokine secretion was elevated and the proportion of SA-β-galactosidase-positive cells (a classical senescence marker) was higher in stimulated CD4+ T cells from LIP mice, accompanied by a reduced fraction of cells in the S phase of the cell cycle, collectively indicating accelerated replicative senescence.
• Adoptive transfer of CD4+ T cells from LIP mice into nude (immunodeficient) mice significantly exacerbated collagen antibody-induced arthritis (CAIA) compared to transfer of control T cells, providing direct functional evidence that periodontitis-primed senescent T cells can worsen systemic autoimmune joint disease.
• RNA-seq of unstimulated splenic helper T cells from LIP mice identified numerous differentially expressed genes enriched in senescence-related pathways, suggesting that periodontitis induces a latent 'senescence-primed' transcriptional state even before overt senescence markers are detectable by surface phenotyping.

Male BALB/c mice ranging from 5 to 42 weeks of age underwent silk ligature placement around the maxillary second molars to induce experimental periodontitis (LIP model); age-matched unligated mice served as controls. Splenic CD4+ T cells were isolated and subjected to in vitro stimulation with IL-2 and anti-TCRβ/CD28 antibodies for 1–3 days to unmask latent senescence phenotypes. Senescence was assessed by flow cytometry for PD-1/CD153 co-expression, SA-β-galactosidase staining, cell-cycle analysis, SASP cytokine profiling, and bulk RNA sequencing. Functional consequences were tested via adoptive transfer of LIP or control CD4+ T cells into nude mice followed by collagen antibody-induced arthritis induction.

As an entirely mouse-based study using an artificial ligature model, direct translation to human periodontitis and rheumatoid arthritis (RA) pathophysiology is uncertain — ligature-induced periodontitis is acute and microbiome-driven in ways that differ from chronic human disease. The study does not establish whether the senescence-primed state persists after periodontal treatment, which is the clinically actionable question. The in vivo senescence marker readout (PD-1+CD153+) did not differ between groups without ex vivo stimulation, raising questions about the physiological relevance of the latent phenotype. Future experiments should test whether periodontal treatment reverses T-cell priming and whether equivalent senescence signatures appear in CD4+ T cells from human RA patients with comorbid periodontitis.

This study extends the chronic-inflammation theme of the corpus by proposing a cellular immunosenescence mechanism — rather than purely cytokine-driven or microbiome-driven pathways — as the link between oral and systemic disease. It parallels [§141], which also investigates how periodontal disease exacerbates a distinct systemic inflammatory condition (ulcerative colitis) through immune dysregulation, providing a complementary mechanistic framework across different end-organ targets. The senescence-SASP axis explored here conceptually parallels [§99], which examines cellular senescence and inflammation in aging from a different mechanistic angle, together suggesting that SASP amplification is a convergent driver of age-related chronic disease across tissues. The identification of immunosenescence as a pathogenic driver in an arthritis model also extends [§30], which addresses upstream oxidative-stress and inflammatory pathways in a chronic-disease context, by placing T-cell aging downstream of a peripheral inflammatory stimulus. Taken together, these articles suggest the corpus is building toward a multi-mechanism model in which chronic local inflammation — whether periodontal, metabolic, or oxidative — accelerates systemic immune dysfunction through partly independent but potentially synergistic cellular routes.

• Ulcerative colitis-driven gut dysbiosis exacerbates periodontal bone loss through the gut-oral axis /Th17/Treg imbalance
  Directly parallel study design: both use mouse models to trace how periodontal inflammation worsens a distinct systemic autoimmune/inflammatory disease, but Article 141 focuses on ulcerative colitis via Th17/Treg imbalance and gut dysbiosis rather than CD4+ T-cell senescence, making a side-by-side comparison useful for understanding which immune axes mediate periodontal-systemic crosstalk.
• Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence
  Both articles center on cellular senescence and SASP as drivers of chronic inflammatory disease in aging, but examine different cellular compartments and triggers, allowing readers to assess how broadly the senescence-priming concept applies across tissue contexts.
• Exercise hormone irisin alleviates rheumatoid arthritis by removing dysfunctional mitochondria
  Both use mouse RA models to identify mechanistic drivers of joint inflammation — this article implicating immunosenescence and Article 124 demonstrating exercise as a therapeutic modifier — making comparison useful for understanding whether senostatic or lifestyle interventions could counteract T-cell senescence-driven arthritis exacerbation.
• 1,25-Dihydroxyvitamin D3 mitigates high glucose-induced oxidative stress, inflammation, and extracellular matrix accumulation in glomerular mesangial cells via the ROS/TXNIP/NLRP3 pathway
  Both investigate how a chronic peripheral inflammatory stimulus (periodontal disease here; high-glucose oxidative stress in Article 30) activates downstream inflammatory and cellular-damage cascades relevant to systemic disease, offering a comparative view of upstream triggers that could converge on similar SASP-mediated pathology.